登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《JAMA，4月29日，Internet Searches for Unproven COVID-19 Therapies in the United States》

  • 来源专题：COVID-19科研动态监测
  • 编译者： xuwenwhlib
  • 发布时间：2020-05-02

  • Internet Searches for Unproven COVID-19 Therapies in the United States

    Michael Liu, AB1; Theodore L. Caputi, MPH2; Mark Dredze, PhD3; et alAaron S. Kesselheim, MD, JD, MPH4; John W. Ayers, PhD, MA5

    Author Affiliations Article Information

    JAMA Intern Med. Published online April 29, 2020. doi:10.1001/jamainternmed.2020.1764

    There are no highly effective prescription drug therapies supported by any reliable evidence for the ongoing coronavirus disease 2019 (COVID-19) pandemic of severe acute respiratory syndrome coronavirus 2. However, fears among the public can lead to searches for unproven therapies. Therefore, when several high-profile figures, including entrepreneur Elon Musk and President Donald Trump, endorsed the use of chloroquine, a malarial prophylaxis drug, and hydroxychloroquine (with the antibiotic azithromycin), a lupus and rheumatoid arthritis treatment, to treat COVID-19, it drew massive public attention that could shape individual decision-making.

  • 原文来源：https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2765361
82浏览量
原文链接
相关报告

  • 《JAMA，5月28日，Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-05-29
    • Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States Muthiah Vaduganathan, MD, MPH1; Jeroen van Meijgaard, PhD2; Mandeep R. Mehra, MD, MSc1; et alJacob Joseph, MD3; Christopher J. O’Donnell, MD, MPH3; Haider J. Warraich, MD3 Author Affiliations Article Information JAMA. Published online May 28, 2020. doi:10.1001/jama.2020.9184 Conflicting information regarding the benefits of hydroxychloroquine/chloroquine and azithromycin in coronavirus disease 2019 (COVID-19) treatment and hypothetical concerns for drugs, such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), have challenged care during the pandemic.1 However, limited data are available about how prescription of these therapies has changed. The objective of this exploratory analysis was to evaluate prescription patterns of these therapies, along with other commonly used drugs for reference, in the United States during the COVID-19 pandemic. We hypothesized that the prescription of hydroxychloroquine/chloroquine and azithromycin would exceed historical estimates while ACE inhibitor/ARB use would be reduced.
    177浏览量
    原文链接

  • 《ChinaXiv，3月4日，Psychological responses to the Coronavirus Disease (COVID-19) outbreak》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-05
    • Psychological responses to the Coronavirus Disease (COVID-19) outbreak 提交时间： 2020-03-04 作者： Zheng JIN 1 ; Kaibin ZHAO 1,2 ; Yanyu XIA 1 ; Ruijun CHEN 1 ; Huan YU 1 ; Timothy TAMUNANG TAMUTANA1 1 ; Jeffrey SHERMAN 1,3 ; Christina BERMEITINGER 1,4 ; Pamela BAESS 4 ; 作者单位： 1.Zhengzhou Normal University; 2.Shanghai Normal University; 3.University of California at Davis; 4.University of Hildesheim; The novel coronavirus (COVID-19) has infected more than 90,000 people in at least 69 countries by Feb 29, 2020. Medical interest in COVID-19 has been considerable. Mental health issues that coincide with the epidemics are rarely examined. There is a strong need for public health officials to consider how psychological effects vary at each phase of a crisis and how they relate to people to better support them in these shifting states of mind. The present study examines temporal relationships among behavioral and emotional responses towards COVID-19 and attitudinal responses to crisis management. 846 adults were invited to complete a set of Internet-based questionnaires at two time points with a range of 14 to 18 days’ intervals covered by the ascending phase of the outbreak. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    50浏览量
    原文链接